Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piclidenoson in moderate-to-severe plaque psoriasis
NCT01265667Phase 3Completed
- Sponsor
- Can-Fite BioPharma Ltd.
- Start
- Jul 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of piclidenoson in plaque psoriasis, sponsored by Can-Fite BioPharma Ltd.. Started Jul 2011; status: completed.
02
Drugs
piclidenoson
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01265667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265667.